EB-2 NIWBiotech and pharmaEmployerDecided June 2025Dismissed
Outcome: Dismissed
JUN202025_02B5203
Merit and national importanceNot metWell positionedNot reached / not discussedBalance favors a waiverNot reached / not discussed
Our summary
Business development manager in pharmaceutical sector seeks EB-2 NIW. SCOPS found petitioner qualified for EB-2 and met second Dhanasar prong. AAO held first prong unmet because petitioner conflated general field importance with specific endeavor's national importance; no prospective impact directly attributable to petitioner's work.
Official PDF
Official PDF ↗Published by USCIS. The summary is ours, in our own words; the decision text is on uscis.gov.
No criterion in the table was found met in this decision.
What was missing
- Merit and national importance · Endeavor has substantial merit but lacks national importance; field importance distinct from specific proposed endeavor impact.
Criteria
| Criterion | Reading | Why |
|---|---|---|
 Merit and national importance | Not met | Endeavor has substantial merit but lacks national importance; field importance distinct from specific proposed endeavor impact. |
 Well positioned | Not reached / not discussed | First prong failure dispositive; second prong found met by SCOPS but reserved and not reached on appeal. |
 Balance favors a waiver | Not reached / not discussed | First prong failure dispositive; third prong reserved and not reached. |
A published decision describes one case. It is not legal advice and not a prediction for yours.